Global Ranibizumab Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Ranibizumab Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2039547
  • Published Date :
    May 1, 2022
  • Number of Pages :
    300.0

Product Description

Ranibizumab is a monoclonal antibody fragment obtained from bevacizumab from the same parental murine antibody. It is much smaller than the parent molecule and binds more tightly to vascular endothelial growth factor-A. It is an angiogenesis inhibitor that has been approved for the treatment of "wet" age-related macular degeneration.
The Ranibizumab market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Ranibizumab market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Ranibizumab Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Ranibizumab market are:
Novartis
Genentech

Most important types of Ranibizumab products covered in this report are:
Single-use Prefilled Syringe
Single-use Glass Vial

Most widely used downstream fields of Ranibizumab market covered in this report are:
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Ranibizumab Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Ranibizumab
1.3 Ranibizumab Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Ranibizumab Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Ranibizumab
1.4.2 Applications of Ranibizumab
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Ranibizumab Industry Trends
1.5.2 Ranibizumab Drivers
1.5.3 Ranibizumab Market Challenges
1.5.4 Ranibizumab Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Ranibizumab Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Ranibizumab Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Ranibizumab Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Ranibizumab
2.2.1 Major Players Manufacturing Base of Ranibizumab in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Ranibizumab Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Ranibizumab
2.3.3 Labor Cost of Ranibizumab
2.4 Market Channel Analysis of Ranibizumab
2.5 Major Down Stream Customers by Application

3 Global Ranibizumab Market, by Type
3.1 Global Ranibizumab Revenue and Market Share by Type (2018-2021)
3.2 Global Ranibizumab Production and Market Share by Type (2018-2021)
3.3 Global Ranibizumab Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Ranibizumab Revenue and Growth Rate of Single-use Prefilled Syringe
3.3.2 Global Ranibizumab Revenue and Growth Rate of Single-use Glass Vial
3.4 Global Ranibizumab Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Ranibizumab Market, by Application
4.1 Downstream Market Overview
4.2 Global Ranibizumab Consumption and Market Share by Application (2018-2021)
4.3 Global Ranibizumab Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Ranibizumab Consumption and Growth Rate of wAMD (2018-2021)
4.3.2 Global Ranibizumab Consumption and Growth Rate of Diabetic Retinopathy (DR) (2018-2021)
4.3.3 Global Ranibizumab Consumption and Growth Rate of Diabetic Macular Edema (DME) (2018-2021)
4.3.4 Global Ranibizumab Consumption and Growth Rate of mCNV (2018-2021)
4.3.5 Global Ranibizumab Consumption and Growth Rate of RVO (2018-2021)

5 Global Ranibizumab Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Ranibizumab Revenue and Market Share by Region (2018-2021)
5.2 Global Ranibizumab Consumption and Market Share by Region (2018-2021)
5.3 Global Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Ranibizumab Market Under COVID-19
5.4.2 North America Ranibizumab SWOT Analysis
5.5 Europe Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Ranibizumab Market Under COVID-19
5.5.2 Europe Ranibizumab SWOT Analysis
5.6 China Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Ranibizumab Market Under COVID-19
5.6.2 China Ranibizumab SWOT Analysis
5.7 Japan Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Ranibizumab Market Under COVID-19
5.7.2 Japan Ranibizumab SWOT Analysis
5.8 Middle East and Africa Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Ranibizumab Market Under COVID-19
5.8.2 Middle East and Africa Ranibizumab SWOT Analysis
5.9 India Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Ranibizumab Market Under COVID-19
5.9.2 India Ranibizumab SWOT Analysis
5.10 South America Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Ranibizumab Market Under COVID-19
5.10.2 South America Ranibizumab SWOT Analysis
5.11 South Korea Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Ranibizumab Market Under COVID-19
5.11.2 South Korea Ranibizumab SWOT Analysis
5.12 Southeast Asia Ranibizumab Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Ranibizumab Market Under COVID-19
5.12.2 Southeast Asia Ranibizumab SWOT Analysis

6 Global Ranibizumab Production by Top Regions (2018-2021)
6.1 Global Ranibizumab Production by Top Regions (2018-2021)
6.2 North America Ranibizumab Production and Growth Rate
6.3 Europe Ranibizumab Production and Growth Rate
6.4 China Ranibizumab Production and Growth Rate
6.5 Japan Ranibizumab Production and Growth Rate
6.6 India Ranibizumab Production and Growth Rate

7 Global Ranibizumab Consumption by Regions (2018-2021)
7.1 Global Ranibizumab Consumption by Regions (2018-2021)
7.2 North America Ranibizumab Consumption and Growth Rate
7.3 Europe Ranibizumab Consumption and Growth Rate
7.4 China Ranibizumab Consumption and Growth Rate
7.5 Japan Ranibizumab Consumption and Growth Rate
7.6 Middle East & Africa Ranibizumab Consumption and Growth Rate
7.7 India Ranibizumab Consumption and Growth Rate
7.8 South America Ranibizumab Consumption and Growth Rate
7.9 South Korea Ranibizumab Consumption and Growth Rate
7.10 Southeast Asia Ranibizumab Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Novartis Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Ranibizumab Product Profiles, Application and Specification
8.2.3 Novartis Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Genentech Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Ranibizumab Product Profiles, Application and Specification
8.3.3 Genentech Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Ranibizumab Market Analysis and Forecast by Type and Application
9.1 Global Ranibizumab Market Revenue & Volume Forecast, by Type (2022-2030)
9.1.1 Single-use Prefilled Syringe Market Revenue and Volume Forecast (2022-2030)
9.1.2 Single-use Glass Vial Market Revenue and Volume Forecast (2022-2030)
9.2 Global Ranibizumab Market Revenue & Volume Forecast, by Application (2022-2030)
9.2.1 wAMD Market Revenue and Volume Forecast (2022-2030)
9.2.2 Diabetic Retinopathy (DR) Market Revenue and Volume Forecast (2022-2030)
9.2.3 Diabetic Macular Edema (DME) Market Revenue and Volume Forecast (2022-2030)
9.2.4 mCNV Market Revenue and Volume Forecast (2022-2030)
9.2.5 RVO Market Revenue and Volume Forecast (2022-2030)

10 Ranibizumab Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2022-2030)
10.2 Europe Market Supply and Demand Forecast (2022-2030)
10.3 China Market Supply and Demand Forecast (2022-2030)
10.4 Japan Market Supply and Demand Forecast (2022-2030)
10.5 Middle East and Africa Market Supply and Demand Forecast (2022-2030)
10.6 India Market Supply and Demand Forecast (2022-2030)
10.7 South America Market Supply and Demand Forecast (2022-2030)
10.8 South Korea Market Supply and Demand Forecast (2022-2030)
10.9 Southeast Asia Market Supply and Demand Forecast (2022-2030)
10.10 Explanation of Market Size Trends by Region
10.11 Ranibizumab Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Biotechnology Industry